Connaughton Bernadette

EDGAR CIK 0001662521

Halozyme Therapeutics, Inc. - HALO

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director
Direct Buys
0
$0
0 Shares
Direct Sells
2
($445,217)
-6,000 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/01/2025
10b5-1
10/01/2025
Sell
-2,000 @ $75.24
 ($150,481) 44,952 (-4.26%) Direct
09/02/2025
10b5-1
09/02/2025
Sell
-4,000 @ $73.68
 ($294,736) 46,952 (-7.85%) Direct